Innovations

Note to the businessman

Longevity in the global market

Forecast of the development of the longevity and anti-aging therapy market, key opportunities and analysis of the leading players until 2028.

19.02.2021

Biotechnologies - into life

Chlorella instead of carrots

Biomass with a high content of carotenoids can be used in various branches of the food and pharmaceutical industry.

04.02.2021

Note to the businessman

Grass beef

About 47% of Russians aged 16 to 40 are already ready to diversify their protein diet with plant-based meat.

01.02.2021

Note to the businessman

Caution: anti-aging!

Companies that are engaged in real projects, no more than 2% in this field, and the remaining 98%, unfortunately, are mostly scammers.

22.12.2020

Innovative Russia

It 's as good as a goat 's milk

In the Union State, they have not been able to establish the production of a unique protein lactoferrin, obtained from the milk of transgenic goats, for many years.

16.12.2020

Note to the businessman

Overview of the MedTech sphere

Of particular interest to investors in the field of medicine are two areas: the introduction of IT solutions in the work of doctors and the development of genetics.

27.11.2020

Note to the businessman

Not just the coronavirus

This year, many startups have entered the market that are not related to the coronavirus, but this does not lose relevance.

26.11.2020

Innovative Russia

Digital Medicine in Russia

Interview with Andrey Almazov, Director of Project Work at the Association of AI Developers and Users in Medicine.

06.11.2020

Innovative Russia

IPO of RUSNANO's "daughter"

Atea Pharmaceuticals, which is part of the portfolio of RosnanoMedInvest LLC, conducted an initial public offering on the NASDAQ stock exchange.

02.11.2020

Note to the businessman

Investing in HYIP

Some experts believe that investors should not bet on winners and losers in the race to develop a coronavirus vaccine.

21.10.2020

Note to the businessman

Venture in Russian

Egor Abramov, Investment Director of the Fort Ross Venture Fund – about the current state of the venture market in Russia.

14.10.2020

Note to the businessman

Moscow Accelerator: results

Startups have attracted more than 50 million rubles of investments: the results of the biomedical track of the Moscow Accelerator have been summed up.

09.10.2020

Innovative Russia

"Era of Fusion"

Interview with Pavel Volchkov, Head of the MIPT Genomic Engineering Laboratory, about the future of genetic technologies in Russia.

09.10.2020

Note to the businessman

Protect employees from covid

Recommendations of Rospotrebnadzor for employers on the prevention of coronavirus infection in the workplace.

29.09.2020

Note to the businessman

Jump into the last car

If you haven't had time to invest in one of the companies developing the coronavirus vaccine, it's not too late to do it now.

01.09.2020

Biotechnologies - into life

The next stage of the race

The COVID-19 vaccine may become available in early 2021 under the emergency protocol.

25.08.2020

Biotechnologies - into life

The first and so far the most accurate

Representatives of the Ulyanovsk company "TestGen" – about their coronavirus test, its history and the most significant features.

22.07.2020

Innovative Russia

Orphan diseases in Russia

There are only a few research centers and laboratories in Russia where orphan diseases and gene pathologies are studied.

03.07.2020

Note to the businessman

Biohacking and the market

How biohacking differs from healthy lifestyle, which companies work in this market and how public institutions react to them.

02.07.2020

Biotechnologies - into life

Skolkovo coronavirus test

The detection time of antibodies in a drop of blood is 10-15 minutes, and the diagnostic sensitivity is 96%.

19.06.2020